中文摘要 |
Macrocytosis, defined as a mean corpuscular volume (MCV) over 100fL, is a frequent erythrocyte abnormality of routine automated complete blood count (CBC) in hospital central hematology laboratories. The etiologies of macrocytosis in different populations have been reported including vitamin B12/folate deficiency, chronic alcoholism, hypothyroidism, liver disease and medicine intervention, such as with chemotherapeutic agents, hydroxyurea and antiretroviral drugs. However, evaluation of macrocytosis not yet been performed in Taiwan, an endemic area with chronic liver disease mostly caused by the infections of hepatitis B and C viruses (HBV and HCV). In this study, a retrospective survey with an objective to characterize macrocytosis from CBC data warehouse was conducted in the central Hematology Laboratory of National Cheng Kung University Hospital, Tainan, Taiwan. During April 1 to May 31, 2013, 637 (male=447, female=190) cases displaying MCV>105fL were recruited. The CBC hemograms, biochemical data and serological markers for HBV and HCV were recorded. The increment of MCV values were stratified into 3 groups (105-110fL, 110-115fL and >115fL). Among the 637 macrocytotic cases, 439 (68.9%) had an anemic hemoglobin (Hb) level (male<13g/dL, female<12g/dL), and the rates for macrocytic anemia were constant among the 3 stratified MCV groups. The increment of MCV was associated with decreased rates of abnormal total bilirubin (p=0.039), and with increased HBV surface antigen (HBsAg) positive (p=0.002). Furthermore, the group with HBsAg positive had higher values of MCV (p=0.002), mean corpuscular hemoglobin (MCH) (p=0.031) and red blood cell distribution width (p<0.001), but a lower platelet count (p<0.001) in the CBC hemograms than did the group with negative HBsAg. Additionally, the MCV values negatively correlated with RBC count but positive correlated with MCH in either the presence or the absence of HBV infection. On contrary, a differential correlation of MCV values with mean corpuscular hemoglobin concentration (p<0.001) was revealed only in the HBsAg-negative cases and with Hb (p=0.023) and hematocrit (p=0.004) in HBsAg-positive cases. In conclusion, our study suggests that the macrocytic phenotypes might display distinct hemograms in patients who were infected with HBV, and checking the laboratory parameters in association with hepatitis B diseases and treatments are highly encouraged for macrocytic cases in an area with high prevalence of chronic hepatitis B. |